(Q40781423)

English

Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways (English)

1 reference

Europe PubMed Central

23 September 2017

author name string

Jones HE

1

1 reference

Europe PubMed Central

23 September 2017

Barrow D

2

1 reference

Europe PubMed Central

23 September 2017

Dutkowski CM

3

1 reference

Europe PubMed Central

23 September 2017

Goddard L

4

1 reference

Europe PubMed Central

23 September 2017

Smith C

5

1 reference

Europe PubMed Central

23 September 2017

Harper ME

6

1 reference

Europe PubMed Central

23 September 2017

Nicholson RI

7

1 reference

Europe PubMed Central

23 September 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

49

1 reference

Europe PubMed Central

23 September 2017

1

1 reference

Europe PubMed Central

23 September 2017

38-47

1 reference

Europe PubMed Central

23 September 2017

Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor expression by Northern analysis and immunohistochemistry in benign and malignant prostatic tumours

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Growth factors in human prostate cancer cells: implications for an improved treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Tyrosine kinase inhibitor as a novel signal transduction and antiproliferative agent: prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

The effects of dihydrotestosterone on the expression of p185(erbB-2) and c-erbB-2 mRNA in the prostatic cell line LNCaP.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Effect of growth factors on estrogen receptor mediated gene expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Role of transforming growth factor-alpha in human prostate cancer cell growth

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Prostatic epidermal growth factor receptors and their regulation by androgens

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Identifiers

10.1002/PROS.1116

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40781423&oldid=1907317849"